Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis

NCT02165345 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02165345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02165345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular-Course and Systemic Juvenile Idiopathic Arthritis
Lead sponsor
Hoffmann-La Roche
Phase
Phase 1
Overall status
Completed
Start date
July 16, 2014
Completion date
November 24, 2021
Enrollment
82 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

juvenile idiopathic arthritis